I refer to your news article above entitled “Ivermectin perlu dinilai dengan ujian klinikal sebeluem diluluskan - Dr Musa Nordin” dated 6 February 2021.
Dr Musa has questioned my call in an earlier article for the immediate approval for the use of Ivermectin as a very safe, easily available and cheap drug (in tablet form) to treat Covid-19 due to the emergency pandemic situation now, with no effective treatment yet for Covid-19.
Firstly, I wish to clarify that there are hardly any vaccine experts in our country today as we do not have a serious human vaccine development industry. The closest expert you may get is some (clinical pharmacologist & toxicologist) who studies the safety effects and efficacy of vaccines and drugs. The most important aspect of any vaccine and drug before it is to be approved for public use, is safety. The government is responsible, via the National Pharmaceutical Regulatory Agency (NPRA), to ensure the safety of all drugs and vaccines and NPRA has so far, done a good job.
In principle, as a former member of a WHO expert panel on chemical safety, I support the need to conduct the three phases of human clinical trials, in the interest of safety, for all vaccines or drugs before they are approved for public consumption. But human clinical trials can take many years and we are now in an emergency situation with many people being infected with Covid-19 and dying every day. Ivermectin could be our savior.
Ivermectin has been used for over 30 years by many millions of people with 3.7 billion doses distributed around the world with no reported severe side effects or deaths from taking it. Many recent studies around the world has shown that Ivermectin is also effective for treating Covid-19 and it has already saved many lives. Contrary to what Dr Musa said, the US National Institutes of Health has on 14 January 2021, upgraded the status of Ivermectin from “against” to “neither for or against” meaning that doctors in the US are now allowed to use Ivermectin to treat Covid-19.
Pfizer experimental vaccine was approved for use in Malaysia (without human clinical trials here) and in the US, under “Emergency Authorisation. So why can’t Ivermectin, which has been proven safe for more than 30 years, be approved under “Emergency Authorisation” as well? It can be used for prophylactic (prevention) purpose and for treating Covid patients. For prophylactic purpose, it can be immediately administered, focusing on public red zones and among the high infections areas first.
Ivermectin can also be considered as an emergency drug to be used PRIOR to the arrival of vaccines from overseas (which may be delayed) as a PLAN B. The most important consideration to make here is the safety of the medication.
If we weigh the pro and cons, I would like to appeal for Ivermectin to be approved as soon as possible for emergency use, and it should also be used under prescription by a doctor, as an additional safety measure.
Professor Dr Mustafa Ali Mohd
Clinical Pharmacologist & Toxicologist
* The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the position of Astro AWANI.
Prof Dr Mustafa Ali Mohd
Mon Feb 08 2021
'Human clinical trials can take many years and we are now in an emergency situation with many people being infected with Covid-19 and dying every day.' - Photo for illustration purpose
Thomas Cup: Permulaan cemerlang buat Malaysia
Malaysia bermula cemerlang pada perlawanan pembukaan Piala Thomas 2024, dengan menewaskan Hong Kong 5-0 hari ini.
PRK Kuala Kubu Baharu: Proses penamaan calon lancar - Polis Selangor
Proses penamaan calon bagi PRK Kuala Kubu Baharu hari ini berjalan lancar tanpa sebarang insiden tidak diingini.
PRK Kuala Kubu Baharu: Pembangunan anak muda, wanita menjadi fokus Pang
Agenda pembangunan anak muda dan wanita akan menjadi fokus utama calon PH Pang Sock Tao, pada PRK Kuala Kubu Baharu.
Nahas helikopter Lumut: Kerajaan tidak bercadang gantung sementara helikoper Fennec, HOM
Kerajaan setakat ini tidak bercadang untuk menggantung sementara perkhidmatan helikopter jenis Fennec dan HOM.
Kejohanan Dunia Boling Padang: Tiga gangsa dalam tangan, misi tukar warna pingat
Skuad boling padang negara layak ke pusingan separuh akhir dalam kesemua kategori yang dipertandingkan di Kejohanan Dunia Dalam Dewan 2024.
Amerika Syarikat mungkin haramkan firma dron China, DJI
Amerika Syarikat kini turut sedang pertimbangkan DJI sebagai ancaman sekuriti, dan mungkin melakukan perundangan untuk mengharamkan DJI.
Bersatu ambil tindakan susulan terhadap enam ahli Parlimen - Muhyiddin
Bersatu sedang melaksanakan tindakan susulan terhadap enam ahli Parlimennya yang menyokong Perdana Menteri selepas meminda Perlembagaan parti bulan lalu.
'Made in Malaysia' - Apple punyai 19 kilang pembekal di negara ini
Malaysia merupakan salah satu negara yang mempunyai beberapa kilang pembekal yang menawarkan komponen kepada Apple.
SPRM lancar bilik gerakan PRK Kuala Kubu Baharu
SPRM melancarkan bilik gerakan, bagi membolehkan orang ramai menyalurkan maklumat serta aduan berkaitan perbuatan rasuah dan salah guna kuasa.
WEF anjur mesyuarat khas di Arab Saudi ketika suhu geopolitik Asia Barat memanas
WEF keluar dari kelazimannya dengan menganjurkan mesyuarat khas dua hari, 28-29 April 2024 di Riyadh, Arab Saudi.
Penduduk Singapura boleh pilih vaksin COVID-19
Kerajaan Singapura menyasarkan kesemua penduduk divaksin menjelang hujung tahun ini.
Ini senarai negara yang gantung penggunaan vaksin AstraZeneca
Indonesia antara negara terbaharu yang menggantung pemberian vaksin COVID-19 buatan AstraZeneca.
Vaksin Sinovac tiba di Malaysia pada 27 Februari
Vaksin Sinovac dijangka mula dibotolkan pada Februari sebelum diedarkan pada Mac oleh Pharmaniaga.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Bekalan vaksin COVID-19 AstraZeneca ke EU dikurangkan
Bekalan dos vaksin syarikat itu ke EU dikurangkan sebanyak 60 peratus, daripada 80 juta kepada 31 juta dos pada suku pertama 2021.
Pelan vaksin COVID-19 negara ambil masa 18 bulan - Khairy
Dewasa sihat bawah usia 60 tahun dan bukan merupakan petugas barisan hadapan dijangka hanya dapat menerima vaksin pada suku ketiga tahun ini atau kemudian.
COVID-19: Kerjasama semua pihak mampu capai imuniti kelompok
Usaha kerajaan melaksanakan Perintah Kawalan Pergerakan (PKP) disifatkan relevan, sementara negara berusaha mencapai tahap imuniti kelompok.
COVID-19: Imuniti kelompok tidak akan tercapai pada 2021 dengan vaksin - Pakar
Jelas seorang pakar, kebergantungan kerajaan kepada vaksin dan kurang perhatian kepada aspek lain tidak akan bantu mencapai kelompok imuniti.
COVID-19: Vietnam bersetuju beli 30 juta dos vaksin AstraZeneca
Vietnam turut sedang berunding untuk mendapatkan vaksin Pfizer, Sputnik V dari Rusia dan vaksin dari China.
US poised to hit 16 million COVID-19 cases within days even as vaccine begins rollout
The United States is poised to hit a record 16 million COVID-19 cases in the coming days and deaths are closing in on the 300,000 mark.